Granzyme and Granulysin Mediated Death of Trypanosoma cruzi

颗粒酶和颗粒溶素介导的克氏锥虫死亡

基本信息

  • 批准号:
    9229525
  • 负责人:
  • 金额:
    $ 62.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-01 至 2021-02-28
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): When killer lymphocytes recognize cells infected with intracellular pathogens, they release their cytotoxic granule contents to induce apoptosis of the infected target cell. However, what happens to intracellular parasites during this process is unclear. Host cell apoptosis is triggered by cytotoxic granule proteases (granzymes, Gzm), delivered into the target cell by the cholesterol-dependent membrane perturbing protein, perforin (PFN). Cytotoxic granules of humans and some other mammals, but not rodents, contain another pore-forming protein, granulysin (GNLY), which preferentially disrupts cholesterol-poor bacterial, fungal and parasite membranes. We recently found that when human killer lymphocytes recognize bacteria-infected cells, they rapidly kill intracellular bacteria. GNLY delivers Gzms into bacteria where they proteolytically attack bacterial electron transport chain complex I to generate toxic superoxide anion and also proteolytically destroy bacterial oxidative defense enzymes. Preliminary data show that GNLY also delivers Gzms into protozoan parasites (Trypanosoma cruzi, Toxoplasma gondii, Leishmania major), which are rapidly killed, also in a superoxide-dependent manner. Destruction of intracellular parasites relies on the concerted action of all three cytotoxic effector molecules - Gzms, PFN and GNLY. Mice that express a GNLY transgene in killer lymphocytes are able to survive a T. cruzi challenge that is lethal to wild-type (WT) mice. This proposal uses T. cruzi as a model to investigate the hypothesis that GNLY, Gzm and PFN-mediated killing of intracellular protozoan parasites provides strong immune protection against intracellular parasites. We hypothesize that T. cruzi amastigotes are killed before the host cell, which limits the spread of infection. We also hypothesize that killer cells rapidly induce programs of cell death in T. cruzi that share some features with death pathways activated by Gzms in mammalian cells or bacteria. We also hypothesize that direct parasite killing helps control acute infection, enhance vaccine protection and reduce the chagasic pathology of chronic infection. This proposal joins the expertise of two principal investigators, who are leaders in studying (1) how killer cells destroy infected host cels and their pathogens and (2) the immune response to T. cruzi. The aims of the proposal are to define the features of killer cell-mediated parasite death, identify T. cruzi Gzm substrates that are important in causing death and explore how direct parasite killing contributes to immune defense by comparing infection in WT mice that do not express GNLY with GNLY-transgenic mice.
 描述(由申请人证明):当杀手淋巴细胞细胞内病原体时,它们释放了totox iC颗粒,构成靶细胞的凋亡。通过胆固醇 - 末期膜蛋白。 ES识别感染细菌的细胞,它们迅速杀死细菌。复杂的I可以生成有毒的超氧化物,以破坏细菌的氧化酶,因此将GZMS交付到寄生虫中(Cruzi,Toxoplasma gondii,Leishmania Major)杀手型淋巴细胞中的Gnly转基因能够在野生型(WT(WT))小鼠中生存,该提案使用T. Cruzi作为一个模型,以研究野生型(WT(WT))的挑战。介导的细胞内原生动物寄生虫对细胞内的寄生虫提供了强烈的免疫保护假设直接的寄生虫杀伤有助于控制慢性感染的急性渗透率,他们是研究的领导者。该提议是杀手细胞细胞寄生虫死亡蚂蚁在造成死亡中的特征,并探讨了直接寄生虫杀伤是如何通过在不表现出与gnly转基因小鼠表达的WT小鼠中构成感染来有助于免疫防御的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICARDO TOSTES GAZZINELLI其他文献

RICARDO TOSTES GAZZINELLI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICARDO TOSTES GAZZINELLI', 18)}}的其他基金

Granzyme and Granulysin Mediated Death of Trypanosoma cruzi
颗粒酶和颗粒溶素介导的克氏锥虫死亡
  • 批准号:
    9104713
  • 财政年份:
    2016
  • 资助金额:
    $ 62.65万
  • 项目类别:
Monocyte-derived dendritic cells in malaria
疟疾中的单核细胞衍生树突状细胞
  • 批准号:
    9282641
  • 财政年份:
    2016
  • 资助金额:
    $ 62.65万
  • 项目类别:
Amazonian Center of Excellence in Malaria Research
亚马逊疟疾研究卓越中心
  • 批准号:
    10441617
  • 财政年份:
    2010
  • 资助金额:
    $ 62.65万
  • 项目类别:
Amazonian Center of Excellence in Malaria Research
亚马逊疟疾研究卓越中心
  • 批准号:
    10598090
  • 财政年份:
    2010
  • 资助金额:
    $ 62.65万
  • 项目类别:
2009 Molecular Approaches for Emergent Re-emergent Tropical Diseases Gordon Resea
2009 年新兴热带病的分子方法 Gordon Resea
  • 批准号:
    7611715
  • 财政年份:
    2009
  • 资助金额:
    $ 62.65万
  • 项目类别:
Role of Polymorphonuclear Phagocytes in Malaria Sepsis
多形核吞噬细胞在疟疾败血症中的作用
  • 批准号:
    7753475
  • 财政年份:
    2009
  • 资助金额:
    $ 62.65万
  • 项目类别:
Role of Polymorphonuclear Phagocytes in Malaria Sepsis
多形核吞噬细胞在疟疾败血症中的作用
  • 批准号:
    7894695
  • 财政年份:
    2009
  • 资助金额:
    $ 62.65万
  • 项目类别:
Innate Immune Receptors for Toxoplasma gondii
弓形虫先天免疫受体
  • 批准号:
    7152613
  • 财政年份:
    2006
  • 资助金额:
    $ 62.65万
  • 项目类别:
Innate Immune Receptors for Toxoplasma gondii
弓形虫先天免疫受体
  • 批准号:
    7676699
  • 财政年份:
    2006
  • 资助金额:
    $ 62.65万
  • 项目类别:
Innate Immune Receptors for Toxoplasma gondii
弓形虫先天免疫受体
  • 批准号:
    7487930
  • 财政年份:
    2006
  • 资助金额:
    $ 62.65万
  • 项目类别:

相似国自然基金

槲皮素调控AMPK/mTOR通路影响急性髓系白血病细胞线粒体功能诱导凋亡与自噬的机制研究
  • 批准号:
    81803783
  • 批准年份:
    2018
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
LncRNA通过miR-21影响的凋亡在造影剂所致急性肾损伤中的发生机制研究
  • 批准号:
    81500520
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
Necroptosis在急性肝衰竭中的发生机制以及Nec-1对急性肝衰竭预后的影响
  • 批准号:
    81501652
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
MicroRNA-210在急性心肌梗死中的作用及其对凋亡-自噬信号通路的影响
  • 批准号:
    81570250
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目

相似海外基金

Role of Creatine Metabolism in Necrotizing Enterocolitis
肌酸代谢在坏死性小肠结肠炎中的作用
  • 批准号:
    10724729
  • 财政年份:
    2023
  • 资助金额:
    $ 62.65万
  • 项目类别:
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
  • 批准号:
    10676628
  • 财政年份:
    2023
  • 资助金额:
    $ 62.65万
  • 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
  • 批准号:
    10648346
  • 财政年份:
    2023
  • 资助金额:
    $ 62.65万
  • 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
  • 批准号:
    10678789
  • 财政年份:
    2023
  • 资助金额:
    $ 62.65万
  • 项目类别:
Novel Inhibitors for Temporal Modulation of T-Lymphocytes during Chronic Heart Failure
慢性心力衰竭期间 T 淋巴细胞时间调节的新型抑制剂
  • 批准号:
    10638340
  • 财政年份:
    2023
  • 资助金额:
    $ 62.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了